AstraZeneca PLC Cash Flow-to-Debt Ratio
AstraZeneca PLC cash flow-to-debt ratio. AstraZeneca PLC (ZEGA) has a Cash Flow-to-Debt Ratio of 0.07x as of September 2025, meaning its operating cash flow of €5.13 Billion could theoretically repay 0% of its total liabilities (€68.48 Billion) in one year. Check cash flow quality index of AstraZeneca PLC to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of AstraZeneca PLC (2014–2024)
Cash flow-to-debt ratio of AstraZeneca PLC from 2014 to 2024. Historical debt coverage capacity for AstraZeneca PLC across 11 annual periods. Check AstraZeneca PLC investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
AstraZeneca PLC Cash Flow-to-Debt Ratio by Year (2014–2024)
AstraZeneca PLC cash flow-to-debt ratio by year from 2014 to 2024. Year-by-year debt coverage analysis for AstraZeneca PLC. For the full cash flow conversion analysis, see ZEGA cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.19x | €11.86 Billion | €63.16 Billion | ▲ +12.3% |
| 2023 | 0.17x | €10.36 Billion | €61.95 Billion | ▲ +1.3% |
| 2022 | 0.17x | €9.81 Billion | €59.42 Billion | ▲ +82.9% |
| 2021 | 0.09x | €5.96 Billion | €66.08 Billion | ▼ -3.9% |
| 2020 | 0.09x | €4.80 Billion | €51.09 Billion | ▲ +48.0% |
| 2019 | 0.06x | €2.97 Billion | €46.78 Billion | ▲ +13.0% |
| 2018 | 0.06x | €2.62 Billion | €46.61 Billion | ▼ -26.7% |
| 2017 | 0.08x | €3.58 Billion | €46.71 Billion | ▼ -15.3% |
| 2016 | 0.09x | €4.14 Billion | €45.86 Billion | ▲ +13.0% |
| 2015 | 0.08x | €3.32 Billion | €41.55 Billion | ▼ -55.8% |
| 2014 | 0.18x | €7.06 Billion | €38.95 Billion | — |